Given that SMYD2 inhibition ameliorates renal injury in cisplatin‐induced CKD mice, cisplatin was administered intraperitoneally to Smyd2tecKO mice (Figure 4D) to investigate whether cisplatin promotes chronic renal injury by upregulating SMYD2 expression. Here, SMYD2 is linked to chronic kidney disease.